Glaucoma, Angle-closure, Primary, Acute
2 clinical trials · Condition
◉ Watch Glaucoma, Angle-closure, Primary, Acute
| Record | Firm | Date |
|---|---|---|
| Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG) (NCT01965106) | Quark Pharmaceuticals | 2013-12-01 |
| Investigating the Neuroprotective Effect of Cop-1 (Copaxone) in Acute Primary Angle Closure (NCT01936129) | Singapore Eye Research Institute | 2010-09-01 |
Track Glaucoma, Angle-closure, Primary, Acute automatically
Every clearance here is in the API, with alerts when new ones post.